The Chemours Company CC
Regular-session close
Pre-market · Nov 20, 8:51 AM ET
- YTD
- +0.08%
- 1 year
- +10.28%
5D -1.47 (-10.84%)
- Market cap
- 1.78B
- Revenue (ttm)
- 5.84B
- Profit margin
- -2.64%
- EPS (ttm)
- -1.12
- Shares out
- 150.52M
- Forward P/E
- 6.84
- Dividend
- 0.35 (2.87%)
- Ex-dividend date
- Nov 16, 2026
- YTD return
- +0.08%
- 1-year return
- +10.28%
- Volume
- 2.29M
- Avg volume
- 2.11M
- Open
- 11.96
- Previous close
- 11.80
- Day's range
- 11.56 – 12.26
- 52-week range
- 10.51 – 28.67
- Beta
- 1.47
- Analysts
- Hold
- Price target
- 16.00 (+35.6%)
- Earnings date
- Feb 18, 2027
Key statistics
- 50-day average
- 13.58
- 200-day average
- 18.23
- Enterprise value
- 5.21B
- PEG ratio
- 1.60
- Price / sales
- 0.30
- Price / book
- 11.45
- Payout ratio
- 1666.67%
- Revenue growth
- 3.00%
- Free cash flow
- 68.75M
- Total cash
- 698.00M
- Total debt
- 4.09B
- Return on equity
- -67.98%
- Short % of float
- 13.54%
Fundamental scorecard
8 of 25 checks passed on CC’s reported financials
8of 25 checks passed
- Value 2 of 5
- Growth 2 of 5
- Profitability 0 of 5
- Financial health 1 of 5
- Dividend 3 of 5
Statements to Sep 30, 2026.
Analyst view
Consensus: hold
- Target (low)
- 14.00
- Target (mean)
- 16.00
- Target (high)
- 18.00
- Strong buy0
- Buy2
- Hold8
- Sell0
- Strong sell0
Next earnings
Feb 18, 2027
Expected Feb 18, 2027. Consensus EPS estimate 0.14013.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 18, 2027 | Dec 30, 2026 | 0.12 | — | — | — |
| Nov 2, 2026 | Sep 30, 2026 | 0.2662 | 0.21 | -0.06 | -21.11% |
| Aug 4, 2026 | Jun 30, 2026 | 0.4887 | 0.42 | -0.07 | -14.06% |
| May 5, 2026 | Mar 31, 2026 | -0.05 | 0.05 | +0.10 | +200.00% |
| Feb 19, 2026 | Dec 31, 2025 | 0.0887 | 0.05 | -0.04 | -43.63% |
| Nov 6, 2025 | Sep 30, 2025 | 0.24 | 0.20 | -0.04 | -16.67% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 9, 2026 | JP Morgan | main | Neutral | Neutral |
| Nov 4, 2026 | UBS | main | Neutral | Neutral |
| Nov 4, 2026 | Truist Securities | main | Buy | Buy |
| Oct 20, 2026 | Truist Securities | main | Buy | Buy |
| Oct 14, 2026 | Mizuho | down | Outperform | Neutral |
| Oct 13, 2026 | Barclays | init | — | Equal-Weight |
About The Chemours Company
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that delivers whiteness, brightness, opacity, durability, efficiency, and protection in applications, including architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard for use in packaging under the Ti-Pure brand name. The Advanced Performance Materials segment products portfolio includes various specialty product solutions, membranes, industrial resins, additives, films, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical markets under the Teflon, Viton, Krytox, and Nafion brand names. It sells its products through direct and indirect channels, as well as through a network of resellers, third-party sales agents, and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Country
- United States
- Website
- chemours.com
News
CC Investors: BFA Law Notifies Chemours Investors with Losses of the Filed Securities Fraud Class Action and Upcoming December 7 Court Deadline
Kaplan Fox Alerts The Chemours Company (CC) Investors to an Approaching Lead Plaintiff Deadline on December 7, 2026
CC Investors Have Opportunity to Lead The Chemours Company Securities Fraud Lawsuit with SBS Law
The Chemours Company Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CC
Faruqi & Faruqi, LLP Urges The Chemours (CC) Investors to Seek Counsel Before the December 7, 2026 Lead Plaintiff Deadline in the Securities Class Action
CC Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in The Chemours Company Securities Lawsuit - Contact SueWallSt
Chemours Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against The Chemours Company - CC
The Chemours Company Announces Retirement of Kristine Wellman and Appointment of Amy Rocklin as General Counsel
What's Next for The Chemours Company Shareholders After 18.63% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline
Bronstein, Gewirtz & Grossman LLC Urges Chemours Company Investors to Act: Class Action Filed Alleging Investor Harm
Your note
Sign in to keep a note on CC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CRANSTON MARY B | Director | Purchase | Aug 6, 2026 | 113,141 |
| DIGNAM DENISE | Chief Executive Officer | Purchase | Aug 10, 2026 | 339,916 |
| FAMILIAR CALDERON GERARDO | Officer | Purchase | Aug 11, 2026 | 58,547 |
| FARRELL DAWN LORRAINE | Director | Stock Award(Grant) | Apr 21, 2025 | 97,636 |
| FOLEY MICHAEL ROBERT | Officer | Purchase | Aug 6, 2026 | 80,777 |
| GUMPEL DAMIAN | Officer | Purchase | Jun 2, 2025 | 131,701 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 14.96% | 22,519,121 | 265.50M | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 7.25% | 10,915,553 | 128.69M | Sep 29, 2026 |
| Vanguard Capital Management LLC | 4.51% | 6,793,012 | 80.09M | Sep 29, 2026 |
| State Street Corporation | 4.04% | 6,083,049 | 71.72M | Sep 29, 2026 |
| JPMORGAN CHASE & CO | 3.83% | 5,763,510 | 67.95M | Sep 29, 2026 |
| Cooper Creek Partners Management LLC | 3.72% | 5,603,764 | 66.07M | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.95% | 8,958,338 | 105.62M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.18% | 4,783,383 | 56.40M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.64% | 3,976,985 | 46.89M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.29% | 3,452,149 | 40.70M | Jun 29, 2026 |
| Columbia Funds Series Trust-Columbia Select Mid Cap Value Fund | 1.52% | 2,281,585 | 26.90M | Aug 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 1.45% | 2,184,649 | 25.76M | Jun 29, 2026 |
